Titre : Nitrophénols

Nitrophénols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Evidence-Based Practice
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nitrophénols : Questions médicales les plus fréquentes", "headline": "Nitrophénols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nitrophénols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nitrophénols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés nitrés", "url": "https://questionsmedicales.fr/mesh/D009574", "about": { "@type": "MedicalCondition", "name": "Composés nitrés", "code": { "@type": "MedicalCode", "code": "D009574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dinitrophénols", "alternateName": "Dinitrophenols", "url": "https://questionsmedicales.fr/mesh/D004140", "about": { "@type": "MedicalCondition", "name": "Dinitrophénols", "code": { "@type": "MedicalCode", "code": "D004140", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.304" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "2,4-Dinitro-phénol", "alternateName": "2,4-Dinitrophenol", "url": "https://questionsmedicales.fr/mesh/D019297", "about": { "@type": "MedicalCondition", "name": "2,4-Dinitro-phénol", "code": { "@type": "MedicalCode", "code": "D019297", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.304.250" } } } ] }, { "@type": "MedicalWebPage", "name": "2-Bromométhyl-4-nitro-phénol", "alternateName": "2-Hydroxy-5-nitrobenzyl Bromide", "url": "https://questionsmedicales.fr/mesh/D015077", "about": { "@type": "MedicalCondition", "name": "2-Bromométhyl-4-nitro-phénol", "code": { "@type": "MedicalCode", "code": "D015077", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.400" } } }, { "@type": "MedicalWebPage", "name": "Niclofolan", "alternateName": "Niclofolan", "url": "https://questionsmedicales.fr/mesh/D009533", "about": { "@type": "MedicalCondition", "name": "Niclofolan", "code": { "@type": "MedicalCode", "code": "D009533", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.600" } } }, { "@type": "MedicalWebPage", "name": "Nitroxinil", "alternateName": "Nitroxinil", "url": "https://questionsmedicales.fr/mesh/D009611", "about": { "@type": "MedicalCondition", "name": "Nitroxinil", "code": { "@type": "MedicalCode", "code": "D009611", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.620" } } }, { "@type": "MedicalWebPage", "name": "Picrates", "alternateName": "Picrates", "url": "https://questionsmedicales.fr/mesh/D010851", "about": { "@type": "MedicalCondition", "name": "Picrates", "code": { "@type": "MedicalCode", "code": "D010851", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.690" } } }, { "@type": "MedicalWebPage", "name": "Tolcapone", "alternateName": "Tolcapone", "url": "https://questionsmedicales.fr/mesh/D000077867", "about": { "@type": "MedicalCondition", "name": "Tolcapone", "code": { "@type": "MedicalCode", "code": "D000077867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.640.743.845" } } } ], "about": { "@type": "MedicalCondition", "name": "Nitrophénols", "alternateName": "Nitrophenols", "code": { "@type": "MedicalCode", "code": "D009596", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sk Aftabul Alam", "url": "https://questionsmedicales.fr/author/Sk%20Aftabul%20Alam", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India." } }, { "@type": "Person", "name": "Pradipta Saha", "url": "https://questionsmedicales.fr/author/Pradipta%20Saha", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India." } }, { "@type": "Person", "name": "Yu Wang", "url": "https://questionsmedicales.fr/author/Yu%20Wang", "affiliation": { "@type": "Organization", "name": "Shanghai Key Laboratory of Agricultural Genetics and Breeding, Agro-Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, 201106, China." } }, { "@type": "Person", "name": "Jin Li", "url": "https://questionsmedicales.fr/author/Jin%20Li", "affiliation": { "@type": "Organization", "name": "Institute for Environmental and Climate Research, Jinan University, Guangzhou 511443, China; Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, Guangzhou 511443, China." } }, { "@type": "Person", "name": "Peizeng Yang", "url": "https://questionsmedicales.fr/author/Peizeng%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Environmental Science and Engineering, Nanjing Agricultural University, Nanjing 210095, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evidence, expertise, and patient/family preferences to maximize health for older adults with implications for evidence-based practice.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36102340", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/wvn.12605" } }, { "@type": "ScholarlyArticle", "name": "Evidence-based practice and clinical practice in child language: an online survey with Brazilian speech-language pathologists.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37970891", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232022272pt" } }, { "@type": "ScholarlyArticle", "name": "Enhancing Quality of Care Through Evidence-Based Practice: Training and Supervision Experiences.", "datePublished": "2023-04-07", "url": "https://questionsmedicales.fr/article/37026189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1176/appi.psychotherapy.20220015" } }, { "@type": "ScholarlyArticle", "name": "Evidence-based practices in developing and maintaining clinical nurse preceptors: An integrative review.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35863086", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nedt.2022.105468" } }, { "@type": "ScholarlyArticle", "name": "The validity and reliability properties of a Persian version of the evidence-based practice profile (EBP", "datePublished": "2024-10-14", "url": "https://questionsmedicales.fr/article/39402622", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06139-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Composés nitrés", "item": "https://questionsmedicales.fr/mesh/D009574" }, { "@type": "ListItem", "position": 4, "name": "Nitrophénols", "item": "https://questionsmedicales.fr/mesh/D009596" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nitrophénols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nitrophénols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nitrophénols", "description": "Comment diagnostiquer une intoxication aux nitrophénols ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication ?\nLes nitrophénols sont-ils détectables par imagerie ?\nY a-t-il des marqueurs biologiques spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nitrophénols", "description": "Quels sont les symptômes d'une exposition aiguë ?\nLes nitrophénols provoquent-ils des effets chroniques ?\nComment les nitrophénols affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la dose ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nitrophénols", "description": "Comment prévenir l'exposition aux nitrophénols ?\nLes travailleurs doivent-ils être formés ?\nQuelles sont les mesures de sécurité en laboratoire ?\nLes nitrophénols sont-ils réglementés ?\nComment gérer les déversements de nitrophénols ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nitrophénols", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les nitrophénols ?\nComment traiter les irritations cutanées causées par les nitrophénols ?\nLe charbon actif est-il utile en cas d'ingestion ?\nQuand faut-il hospitaliser un patient exposé ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nitrophénols", "description": "Quelles complications peuvent survenir après une exposition ?\nLes effets sont-ils réversibles ?\nY a-t-il un risque de cancer lié aux nitrophénols ?\nComment surveiller les complications à long terme ?\nLes complications varient-elles selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nitrophénols", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes antécédents médicaux influencent-ils le risque ?\nLes enfants sont-ils plus à risque ?\nL'environnement joue-t-il un rôle ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Evidence-Based+Practice&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux nitrophénols ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les nitrophénols." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux de nitrophénols." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées, et des troubles respiratoires." } }, { "@type": "Question", "name": "Les nitrophénols sont-ils détectables par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les nitrophénols; des tests biochimiques sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la présence de métabolites spécifiques dans l'urine peut indiquer une exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des vertiges, des nausées, et des irritations cutanées." } }, { "@type": "Question", "name": "Les nitrophénols provoquent-ils des effets chroniques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition chronique peut entraîner des troubles neurologiques et hépatiques." } }, { "@type": "Question", "name": "Comment les nitrophénols affectent-ils le système respiratoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des irritations des voies respiratoires et des difficultés respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus graves, comme des convulsions et des vomissements." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux nitrophénols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Quelles sont les mesures de sécurité en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les nitrophénols sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est réglementée pour minimiser les risques d'exposition." } }, { "@type": "Question", "name": "Comment gérer les déversements de nitrophénols ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des kits de déversement et suivre les protocoles d'urgence appropriés." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les nitrophénols ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique; le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par les nitrophénols ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il faut rincer la zone affectée à l'eau et appliquer des crèmes apaisantes." } }, { "@type": "Question", "name": "Le charbon actif est-il utile en cas d'ingestion ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le charbon actif peut être administré pour réduire l'absorption en cas d'ingestion." } }, { "@type": "Question", "name": "Quand faut-il hospitaliser un patient exposé ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou d'exposition prolongée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des lésions hépatiques, des troubles neurologiques et respiratoires." } }, { "@type": "Question", "name": "Les effets sont-ils réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Y a-t-il un risque de cancer lié aux nitrophénols ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Comment surveiller les complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux réguliers et des tests fonctionnels sont recommandés pour le suivi." } }, { "@type": "Question", "name": "Les complications varient-elles selon l'âge ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées peuvent être plus vulnérables aux complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en chimie, les laboratoires et les sites industriels sont à risque élevé." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies hépatiques ou respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de leur taille et de leur métabolisme, les enfants sont plus vulnérables." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre près d'industries utilisant des nitrophénols augmente le risque d'exposition." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines habitudes, comme le tabagisme, peuvent exacerber les effets des nitrophénols." } } ] } ] }

Sources (10000 au total)

Evidence, expertise, and patient/family preferences to maximize health for older adults with implications for evidence-based practice.

As Americans live longer and with chronic conditions, the healthcare system, researchers, faculty, practicing providers, patients, and families must adapt to changing societal needs and goals.... The aim of this commentary was to offer recommendations that align with the six vital directions to improve the health care and quality of life for older Americans.... This article expands upon the six vital directions from an evidence-based practice (EBP) perspective that values the three legs of the EBP stool: (1) research evidence, (2) clinician expertise, and (3... The recommendations reflect the scientific literature, our expertise in EBP and research, our nursing roles and expertise, and our experiences in the care of our older parents. By sharing our experien... Vital directions for improving the health care and quality of life for older Americans include promoting interprofessional education to create an adequately prepared workforce; researching and impleme...

Evidence-based practice and clinical practice in child language: an online survey with Brazilian speech-language pathologists.

To characterize the knowledge, skills, opinions, and main barriers perceived by speech-language pathologists, in child language in Brazil, regarding evidence-based practice (EBP).... The study was conducted between August 2021 and July 2022 using an online questionnaire. In addition to sociodemographic and field data, 22 items related to EBP were considered and subdivided into "kn... Although most speech-language pathologists report having learned the basics of EBP in their academic training, there are weaknesses in their knowledge and lack of mastery of search strategies and crit... This study alerts the academic community to the urgency of considering EBP in the context of Brazilian Speech-Language Pathology....

Enhancing Quality of Care Through Evidence-Based Practice: Training and Supervision Experiences.

Evidence-based practice (EBP) is the preferred approach to treatment in mental health settings because it involves the integration of the best available research, clinical expertise, and patient value... Electronic surveys were completed by 69 therapists, most of whom had a master's degree, within a psychiatry and behavioral sciences department at an academic institution. Participating therapists were... Although most therapists reported completing some form of EST-related coursework, a majority did not receive any supervision related to implementation of ESTs (51% for cognitive-behavioral therapy cas... Although research from the past decade has supported the need for improvements in training on ESTs, and especially in supervision, problems related to limited exposure to training and supervision amon...

Evidence-based practices in developing and maintaining clinical nurse preceptors: An integrative review.

This integrative review of literature explores the best practice for establishing and maintaining a hospital-based nurse preceptor program. The intent is to provide nurse leadership and educators with... The project team conducted an integrative review of literature to inform best practice using the Johns Hopkins Evidence-Based Practice Model and Guidelines.... Data sources included the PubMed, CINAHL, and Cochrane databases.... Each applicable article underwent a rigorous review and appraisal by the project team. The team used the Johns Hopkins Evidence-Based Practice Model to guide the appraisal process and to synthesize re... The search yielded 115 unique articles that answered the evidence-based practice question. What are best practices for establishing and maintaining a hospital-based nursing preceptor program? Due to t... Many preceptorship themes and recommendations resonate throughout multiple levels of evidence. Recommendations include implementing an evidence-based, standardized curriculum that features diverse tea...

The validity and reliability properties of a Persian version of the evidence-based practice profile (EBP

Evidence-based medicine is defined as searching for medical information, reviewing and comparing it to each patient's situation, and then judging the optimal decision. We aimed to measure the psychome... This cross-sectional study was conducted in 2021. The EBP2 questionnaire, which includes 74 five-Likert-scale items, was translated into the Persian language using the forward-backward translation met... Overall, 339 students participated in this study. The cultural adaptability, linguistic equivalence, and content validity of the Persian version of the EBP... The study's findings indicate that the Persian translated of the EBP2 questionnaire exhibited satisfactory validity and reliability for assessing students' evidence-based performance in health-related...

The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder.

The objective of this article was to provide an overview of the development and recommendations from the Australian evidence-based clinical practice guideline for attention deficit hyperactivity disor... Development integrated the best available evidence with multidisciplinary clinical expertise and the preferences of those with lived experience, underpinned by the Grading of Recommendations, Assessme... The 113 clinical recommendations apply to young children (5 years and under), children, adolescents and adults. They provide guidance for clinicians on identification, screening, diagnosis, multimodal... The guideline was approved by the National Health and Medical Research Council (NHMRC) of Australia and relevant medical and allied health professional associations. It is anticipated that successful ...

The perspectives of Australian speech pathologists in providing evidence-based practices to children with autism.

Bridging the research-practice gap in autism communication services is an identified priority for improving services. Limited research has investigated the views of practitioners regarding this resear... To elucidate how Australian speech pathologists engage with external evidence and how communication outcomes are measured to demonstrate the effectiveness of service provision to children with autism.... A total of 15 Australian speech pathologists, with experience ranging from less than 1 to more than 16 years, participated in three focus groups. Data from focus groups were analysed using reflexive t... Seven themes were identified. Participants reported on the diversity of individuals with autism, their experiences of resource constraints, seeking collegial advice and accessing a diverse range of ev... Individual practitioner skill and beliefs are facilitators to translating research to practice. Interventions to improve clinician use of EBP should address the skill and belief barriers, aiming to in... What is already known on the subject Constrained resources, especially lack of time, is a barrier to routine uptake of best available evidence in clinical services for children with autism. What this ...

Knowledge, attitude, understanding and implementation of evidence-based practice among Jordanian radiographers.

Evidence-based practice (EBP) has gained attention globally from healthcare professionals and researchers. The aim of this study was to assess Jordanian diagnostic radiographers' knowledge, attitude, ... A paper-based, self-administered questionnaire with two sections was used. The first section included 11 socio-demographic questions and the second section contained 56 questions regarding EBP categor... Responses were received from 203 radiographers, most of them 135 (66.5%) aged 21-30 years. The majority of radiographers agreed or strongly agreed that the application of EBP is necessary for radiogra... This study showed that despite the positive attitude, and beliefs of radiographers toward EBP, and access to information resources, radiographers still need a higher level of confidence in their abili... The findings of this study may help inform restructure of the undergraduate radiography curriculum, training programs or other interventions required to promote or facilitate the adoption of EBP in Jo...